In turn, the activated AKT increased the expression of lncARSR by inhibiting the transcription factors forkhead box protein O1 (FOXO1) and FOXO3a in sunitinib-resistant renal cell carcinoma cells. This evidence concerns the gene FOXO1 and renal cell carcinoma.